Strategies for Targeting SARS CoV-2: Small Molecule Inhibitors—The Current Status
Immunology
[키워드] ACE-2
ACE2
acute respiratory syndrome
ADE
aggravate
angiotensin
Antibody-dependent enhancement
Antiviral
binding
clinical manifestation
combating
Complication
coronavirus strains
country
COVID-19
current
death
disease
economic loss
effective
Efficacy
exhibit
feature
genomic
Health
high mortality
human cell
immunopathology
imperative
include
infected cases
infection with SARS-CoV-2
infections
Inflammation
inhibitor
interfere
Lung injury
mitigate
molecular target
molecule
more difficult
natural antiviral
natural Nrf-2 modulators
NSMIs
oxidative stress
patients
pharmacological agent
Pneumonia
positive
Protein
reported
respiratory
S-protein
SARS-CoV
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 infections
SARS-CoV-2 strain
SARS-CoV2
small molecule inhibitor
spike
status
Strategy
targeting
the SARS-CoV-2
Vaccine
viral entry
viral propagation
[DOI] 10.3389/fimmu.2020.552925 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.552925 PMC 바로가기 [Article Type] Immunology